UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder

Annals of oncology, 2017-04, Vol.28 (4), p.798-803

2017

Volltextzugriff (PDF)

Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer

Japanese journal of clinical oncology, 2012-07, Vol.42 (7), p.591-600

2012

Volltextzugriff (PDF)

Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma

Clinical and experimental allergy, 2016-09, Vol.46 (9), p.1152-1161

2016

Volltextzugriff (PDF)

Adrenal hormones before and after venography during adrenal venous sampling: a self-controlled study

Japanese journal of radiology, 2017-03, Vol.35 (3), p.126-130

2017

Volltextzugriff (PDF)

Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer

Japanese journal of clinical oncology, 2013-02, Vol.43 (2), p.193-199

2013

Volltextzugriff (PDF)

270P Germline BRCA1/2 pathogenic variants in Japanese patients with prostate cancer are predictive factors for androgen receptor-axis-targeted therapy or chemotherapy for castration-resistant prostate cancer

Annals of oncology, 2023-11, Vol.34, p.S1578

2023

Volltextzugriff (PDF)

269P Prostate cancer harboring low COMT expression correlates with a poor prognosis and response to enzalutamide

Annals of oncology, 2023-11, Vol.34, p.S1578

2023

Volltextzugriff (PDF)

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2018-04, Vol.378 (14), p.1277-1290

2018

Volltextzugriff (PDF)

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2015-11, Vol.373 (19), p.1803-1813

2015

Volltextzugriff (PDF)

Pathological complete response to neoadjuvant chemotherapy improves antitumor immune response through reduction of regulatoty T cells in muscle-invasive bladder cancer

European urology, 2024-03, Vol.85, p.S317

2024

Volltextzugriff (PDF)

P228 - Pathological complete response to neoadjuvant chemotherapy improves antitumor immune response through reduction of regulatoty T cells in muscle-invasive bladder cancer

European urology, 2024-03, Vol.85, p.S317-S317

2024

Volltextzugriff (PDF)

222P The association between response to enfortumab vedotin and peripheral neuropathy: A multicenter retrospective study in Japan

Annals of oncology, 2023-11, Vol.34, p.S1561-S1562

2023

Volltextzugriff (PDF)

A0930 - Impact of timing of rejetion cardiovascular events in living donor kidney transplantation: A multicenter retrospective study

European urology, 2024-03, Vol.85, p.S1990-S1990

2024

Volltextzugriff (PDF)

Impact of timing of rejetion cardiovascular events in living donor kidney transplantation: A multicenter retrospective study

European urology, 2024-03, Vol.85, p.S1990

2024

Volltextzugriff (PDF)

Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis

European urology, 2023-02, Vol.83, p.S1505-S1506

2023

Volltextzugriff (PDF)

A1042 - Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis

European urology, 2023-02, Vol.83, p.S1505-S1506

2023

Volltextzugriff (PDF)

A0925 - Detection of individualized mutations and monitoring of postoperative recurrence using circulating tumor DNA in patients with upper tract urothelial carcinoma

European urology, 2023-02, Vol.83, p.S1319-S1320

2023

Volltextzugriff (PDF)

Detection of individualized mutations and monitoring of postoperative recurrence using circulating tumor DNA in patients with upper tract urothelial carcinoma

European urology, 2023-02, Vol.83, p.S1319-S1320

2023

Volltextzugriff (PDF)

A0747 - Germline HLA-DQB103:01 is an independent prognostic factor for clinical outcomes in patients with urothelial cancer treated with pembrolizumab

European urology, 2024-03, Vol.85, p.S1722-S1723

2024

Volltextzugriff (PDF)

Germline HLA-DQB103:01 is an independent prognostic factor for clinical outcomes in patients with urothelial cancer treated with pembrolizumab

European urology, 2024-03, Vol.85, p.S1722-S1723

2024

Volltextzugriff (PDF)

Study of the prediction system for clinical response to M-VAC neoadjuvant chemotherapy for bladder cancer

Aktuelle Urologie, 2010-01, Vol.41 Suppl 1, p.S41

2010

Volltextzugriff (PDF)

MP-16.16: Imbalance of PTEN, pAkt and p27 expression in acquired cystic disease of the kidney associated with renal cell carcinoma

Urology (Ridgewood, N.J.), 2007, Vol.70 (3), p.127-127

2007

Volltextzugriff (PDF)

P170 - Effect of HLA genotype on anti-PD-1 antibody treatment for advanced renal cell carcinoma

European urology, 2024-03, Vol.85, p.S238-S239

2024

Volltextzugriff (PDF)

Effect of HLA genotype on anti-PD-1 antibody treatment for advanced renal cell carcinoma

European urology, 2024-03, Vol.85, p.S238-S239

2024

Volltextzugriff (PDF)

Adrenal hormones before and after venography during adrenal venous sampling: a self-controlled study

Japanese journal of radiology, 2017-03, Vol.35 (3), p.126-130

2017

Volltextzugriff (PDF)

1 – 25 von 268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(225)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder

Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer

Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma

Adrenal hormones before and after venography during adrenal venous sampling: a self-controlled study

Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer

270P Germline BRCA1/2 pathogenic variants in Japanese patients with prostate cancer are predictive factors for androgen receptor-axis-targeted therapy or chemotherapy for castration-resistant prostate cancer

269P Prostate cancer harboring low COMT expression correlates with a poor prognosis and response to enzalutamide

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Pathological complete response to neoadjuvant chemotherapy improves antitumor immune response through reduction of regulatoty T cells in muscle-invasive bladder cancer

P228 - Pathological complete response to neoadjuvant chemotherapy improves antitumor immune response through reduction of regulatoty T cells in muscle-invasive bladder cancer

222P The association between response to enfortumab vedotin and peripheral neuropathy: A multicenter retrospective study in Japan

A0930 - Impact of timing of rejetion cardiovascular events in living donor kidney transplantation: A multicenter retrospective study

Impact of timing of rejetion cardiovascular events in living donor kidney transplantation: A multicenter retrospective study

Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis

A1042 - Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis

A0925 - Detection of individualized mutations and monitoring of postoperative recurrence using circulating tumor DNA in patients with upper tract urothelial carcinoma

Detection of individualized mutations and monitoring of postoperative recurrence using circulating tumor DNA in patients with upper tract urothelial carcinoma

A0747 - Germline HLA-DQB103:01 is an independent prognostic factor for clinical outcomes in patients with urothelial cancer treated with pembrolizumab

Germline HLA-DQB103:01 is an independent prognostic factor for clinical outcomes in patients with urothelial cancer treated with pembrolizumab

Study of the prediction system for clinical response to M-VAC neoadjuvant chemotherapy for bladder cancer

MP-16.16: Imbalance of PTEN, pAkt and p27 expression in acquired cystic disease of the kidney associated with renal cell carcinoma

P170 - Effect of HLA genotype on anti-PD-1 antibody treatment for advanced renal cell carcinoma

Effect of HLA genotype on anti-PD-1 antibody treatment for advanced renal cell carcinoma

Adrenal hormones before and after venography during adrenal venous sampling: a self-controlled study

Suchergebnisse filtern